Invalidation of HOXA9 expression in those cells impairs proliferation and leukemic properties, and re-activates differentiation processes, showing that HOXA9 is a functional target to restore differentiation in AML [47,99,100,101]. This evidence concerns the gene HOXA9 and acute myeloid leukemia.